Cargando…

TB-6 Experimental evaluation of the therapeutic potential of boron neutron capture therapy in primary central nervous system lymphoma

Background: High-dose methotrexate and whole brain radiation therapy (WBRT) is the recommended treatment for primary central nervous system lymphoma (PCNSL). Although the initial treatment is successful, the recurrence rate is high and the prognosis is poor. Boron neutron capture therapy (BNCT) is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Kohei, Kashiwagi, Hideki, Kawabata, Shinji, Fukuo, Yusuke, Takeuchi, Koji, Hiramatsu, Ryo, Hu, Naonori, Tanaka, Hiroki, Suzuki, Minoru, Miyatake, Shin-Ichi, Wanibuchi, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648232/ http://dx.doi.org/10.1093/noajnl/vdab159.023

Ejemplares similares

Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation
por: Yoshimura, Kohei, et al.
Publicado: (2021)

ET-5 Biological effects of simultaneous use of multiple drugs in neutron capture therapy using rat brain tumor model
por: Kawabata, Shinji, et al.
Publicado: (2021)

ET-4 BASIC RESEARCH OF BORON NEUTRON CAPTURE THERAPY USING A NOVEL BORON COMPOUND TARGETED TO INTEGRIN
por: Tsujino, Kohei, et al.
Publicado: (2022)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model
por: Tsujino, Kohei, et al.
Publicado: (2023)

Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model
por: Fujikawa, Yoshiki, et al.
Publicado: (2023)

TB-03 THE SURVIVAL PROLONGATION EFFECT OF NOVEL BORON COMPOUND FOR BNCT USING RAT BRAIN TUMOR MODEL
por: Fukuo, Yusuke, et al.
Publicado: (2019)

Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model
por: Kashiwagi, Hideki, et al.
Publicado: (2023)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
por: Miyatake, Shin-Ichi, et al.
Publicado: (2020)

Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
por: Fukumura, Masao, et al.
Publicado: (2023)

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
por: Takahara, Kiyoshi, et al.
Publicado: (2015)

Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
por: Hattori, Yoshihide, et al.
Publicado: (2023)

RT-5 Boron Neutron Capture Therapy has extended progression-free survival about recurrent malignant peripheral nerve sheath tumor - A case report
por: Watanabe, Yuko, et al.
Publicado: (2021)

Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan
por: Matsumura, Akira, et al.
Publicado: (2023)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

STMO-07 Adverse events related to the glioblastoma surgery and their perioperative management in our hospital
por: Kashiwagi, Hideki, et al.
Publicado: (2020)

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies
por: Monti Hughes, Andrea, et al.
Publicado: (2023)

Improvement in the neutron beam collimation for application in boron neutron capture therapy of the head and neck region
por: Hu, Naonori, et al.
Publicado: (2022)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

Development of optimization method for uniform dose distribution on superficial tumor in an accelerator-based boron neutron capture therapy system
por: Sasaki, Akinori, et al.
Publicado: (2023)

Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
por: Morris, G. M., et al.
Publicado: (1997)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
por: Barth, Rolf F, et al.
Publicado: (2012)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy
por: Shirakawa, Makoto, et al.
Publicado: (2021)

ET-9 Development of photosensitive antibodies for near-infrared light immunotherapy targeting EGFR and IL13Rα2 of malignant gliomas and investigation of their photodynamic cytotoxic activity in vitro
por: Nonoguchi, Naosuke, et al.
Publicado: (2021)

A Case of Puncture-Site Giant Pseudoaneurysm Following Recanalization Therapy for Acute Ischemic Stroke: Marked Growth and Rupture of a Femoral Artery Pseudoaneurysm
por: Matsubara, Noriaki, et al.
Publicado: (2021)

Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter
por: Hu, Naonori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p2oc35ppb6ccocmi1l9ucakop9